摘要: |
[摘要] 目的 探讨他汀类药物对急性冠脉综合征(ACS)并肾功能不全患者脂代谢水平的影响。方法 选取2013-02~2014-07该院收治的96例ACS并肾功能不全患者,随机抽签分为常规组40例和他汀类药物组56例。常规组采用阿司匹林、β受体阻滞剂、硝酸酯类和血管紧张素转换酶抑制剂等常规药物治疗,他汀类药物组在常规治疗基础上采用他汀类药物治疗。他汀类药物组再分为小剂量组和大剂量组各28例,小剂量组采用小剂量他汀类药物治疗,大剂量组采用大剂量他汀类药物治疗,治疗3个月。观察常规组和他汀类药物组、小剂量组和大剂量组的总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C)等血脂指标变化。结果 治疗前常规组和他汀类药物组血脂指标TC、TG、LDL-C、HDL-C比较差异无统计学意义(P>0.05);治疗后他汀类药物组TC[(4.34±0.63)mmol/L]、TG[(1.56±0.52)mmol/L]、LDL-C[(2.43±0.62)mmol/L]分别较常规组[(5.21±0.75)mmol/L、(2.15±0.73)mmol/L、(2.91±0.81)mmol/L]明显降低,差异有统计学意义(P<0.05)。他汀类药物大剂量组TC[(4.04±0.65)mmol/L]、TG[(1.24±0.57)mmol/L]较小剂量组[(4.65±0.68)mmol/L、(1.75±0.74)mmol/L]显著降低,差异有统计学意义(P<0.05)。结论 他汀类药物能有效降低ACS并肾功能不全患者脂代谢水平,且大剂量他汀类药物降脂效果更佳。 |
关键词: 急性冠脉综合征 肾功能不全 他汀类药物 脂代谢 |
DOI:10.3969/j.issn.1674-3806.2017.01.14 |
分类号:R 692 |
基金项目: |
|
Effect of statins on lipid metabolism levels in patients with acute coronary syndrome complicated with renal dysfunction |
ZHOU Chun-juan
|
Department of Internal Medicine-Cardiovascuilar, Wenxian County Second People′s Hospital, Henan 454850, China
|
Abstract: |
[Abstract] Objective To study the effect of statins on lipid metabolism levels in patients with acute coronary syndrome(ACS) complicated with renal dysfunction.Methods Ninety-six patients with ACS complicated with renal dysfunction treated in our hospital from February 2013 to July 2014 were selected and randomly divided into 3 groups among whom 40 cases treated with routine drugs such as aspirin, β-blockers, nitrates and angiotensin converting enzyme inhibitors were taken as the routine group. The remaining 56 patients treated with statins based on the routine treatment were taken as the statins group; The statins group was subdivided into two groups, in which 28 patients were treated with low-dose statins were taken as the low-dose group while the other 28 cases were treated with high-dose statins(the high-dose group). The treatment lasted for 3 months. The changes of serum lipids indexes such as total cholesterol(TC), triglyceride(TG), low density lipoprotein cholesterol(LDL-C) and high density lipoprotein cholesterol(HDL-C) were observed in the routine group, statins group, low-dose and high-dose group.Results After the treatment, TC, TG and LDL-C of the statins group were significantly lower than those of the routine group[(4.34±0.63) vs (5.21±0.75)mmol/L,(1.56±0.52) vs (2.15±0.73)mmol/L,(2.43±0.62) vs (2.91±0.81)mmol/L](P<0.05); TC and TG of the high-dose group of the statins group were significantly lower than those of the low-dose group[(4.04±0.65) vs (4.65±0.68)mmol/L,(1.24±0.57) vs (1.75±0.74)mmol/L](P<0.05).Conclusion Statins can effectively reduce the lipid level in patients with ACS and complicated with renal dysfunction and the effect of high-dose statins is better. |
Key words: Acute coronary syndrome Renal dysfunction Statins Lipid metabolism |